Last update 30 Jun 2026

DNP-002

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
CEACAM6
Action
inhibitors
Mechanism
CEACAM6 inhibitors(Carcinoembryonic antigen related cell adhesion molecule 6 inhibitors)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Advanced Malignant Solid NeoplasmSolid tumor
Originator Organization
DiNonA, Inc.DiNonA, Inc.
Active Organization-
Inactive Organization
KUMHO HT, Inc.KUMHO HT, Inc.DiNonA, Inc.DiNonA, Inc.
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with DNP-002
NCT06466265
/ Unknown statusPhase 1
An Open-label, Dose-finding, Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of DNP002 in Patients With Advanced Solid Tumors
KCT0006514
/ RecruitingPhase 1
An Open-label, Dose-finding, Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of DNP002 in Patients with Advanced Solid Tumors
100 Clinical Results associated with DNP-002
Login to view more data
100 Translational Medicine associated with DNP-002
Login to view more data
100 Patents (Medical) associated with DNP-002
Login to view more data
100 Deals associated with DNP-002
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
South Korea
KUMHO HT, Inc.KUMHO HT, Inc.
24 May 2021
Solid tumorPreclinical
South Korea
DiNonA, Inc.DiNonA, Inc.
01 May 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT06466265
Phase 1
Solid tumor
16
ruilaogooa(hqfhlvirht) = pgwerufipy orxqqecesm (xsuqorngxr )
View more
Positive
06 Dec 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free